NEW YORK, Sept. 9, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that its confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD did not achieve statistical significance on the primary endpoint, whi

SAN DIEGO, Sept. 9, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) presented new patient-reported outcomes data for olorinab, an investigational, oral, periph

WARSAW, Ind., Sept. 9, 2019 /PRNewswire/ -- Johnson & Johnson Medical Devices Companies* announced today that DePuy Synthes** is launching the ATTUNE Cementless Knee in a rotating platform option in select markets around the world. This launch combines the proprietary technologies of the ATTUNE Knee designed to provide stability while the knee is in motion with

STOCKHOLM, Sept. 9, 2019 /PRNewswire/ -- Lipidor AB (publ) today reports that the last patient has been enrolled in the ongoing phase III study using calcipotriol spray against mild to moderate psoriasis. Results from the study are expected to be presented in December 2019. Lipidor has developed a sprayable calcipotriol product, Calcipotriol/AKVANO 50 µ

DENVER, Sept. 9, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company"), announced today that it has entered into a binding term sheet to acquire four additional dispensaries in Colorado from a leading cannabis retailer.

VANCOUVER, Sept. 9, 2019 /PRNewswire/ - Nextleaf Solutions Ltd. ("Nextleaf Solutions", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) announced today that Nextleaf Labs Ltd. ("Nextleaf Labs" or "Labs"), has received its Standard Processing Licence from Health Canada. This represents an im

SAN JOSE, Calif., Sept. 9, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the fiscal quarter ended July 31, 2019.

SALT LAKE CITY and ANAHEIM, Calif., Sept. 9, 2019 /PRNewswire/ -- CenExel Clinical Research, Inc., ("CenExel" or the "Company") announced that Anaheim Clinical Trials (ACT), an adult and pediatric Phase I through Phase IV clinical research Center of Excellence, recently underwent three separate routine national agency audits within 4

- Tuesday, September 10, 2019 – 4:15 p.m. ET - MISSISSAUGA, ON, Sept. 9, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of co

NEW YORK, Sept. 9, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced results from the Special Meeting of Shareholders held on September 5th (the "Meeting").